Asenov Yavor, Akın Melih, Cantez Serdar, Gün Soysal Feryal, Tekant Yaman
Clinical Center of Gastroenterology, Medical University of Sofia, University Hospital "Tsaritsa Yoanna - ISUL", Sofia, Bulgaria.
Department of Pediatric Surgery, Health Sciences University Şişli Hamidiye Etfal Hospital, İstanbul, Turke.
Turk J Gastroenterol. 2019 Feb;30(2):192-197. doi: 10.5152/tjg.2018.18165.
BACKGROUND/AIMS: To investigate the safety and long-term results of endoscopic retrograde cholangiopancreatography (ERCP) in children with a literature review.
All patients within the age range of 6-17 years who underwent ERCP between 1994 and 2014 at our institution were retrospectively evaluated.
Twenty-four patients with a median age of 15 years underwent ERCP. Cannulation of the papilla was achieved in all patients (100%) without the use of needle-knife papillotomy. Before 1999, ERCP was used as a diagnostic method only in 7 patients (29%). In 17 (71%) patients, the procedure was used for therapeutic purposes. The indications were choledocholithiasis (10 cases, 42%), postoperative complications (5 patients, 21%), and recurrent pancreatitis (2 cases, 8%). In 2 patients (8%), the therapeutic effect was not achieved, thus requiring subsequent operations. There were no major complications. Mild pancreatitis occurred in only 1 patient (4%). Long-term follow-up information was obtained in 16 (67%) patients (median, 18 years; range, 3.5-22.5 years), and no long-term complications were detected.
Endoscopic retrograde cholangiopancreatography is a valuable tool in the diagnosis and treatment of pancreatobiliary disorders in the pediatric population. Large-scale studies are required to create evidence-based guidelines specific to children.
背景/目的:通过文献回顾研究儿童内镜逆行胰胆管造影术(ERCP)的安全性及长期效果。
对1994年至2014年在本机构接受ERCP的6至17岁所有患者进行回顾性评估。
24例患者接受了ERCP,中位年龄为15岁。所有患者(100%)均成功完成乳头插管,未使用针刀乳头切开术。1999年前,仅7例患者(29%)将ERCP用作诊断方法。17例患者(71%)该操作用于治疗目的。适应证为胆总管结石(10例,42%)、术后并发症(5例,21%)和复发性胰腺炎(2例,8%)。2例患者(8%)治疗效果未达预期,因此需要后续手术。无严重并发症。仅1例患者(4%)发生轻度胰腺炎。16例患者(67%)获得长期随访信息(中位时间18年;范围3.5至22.5年),未发现长期并发症。
内镜逆行胰胆管造影术是诊断和治疗儿童胰胆疾病的重要工具。需要开展大规模研究以制定针对儿童的循证指南。